Institution
China National Biotechnology (China)
CNcompany
Recent research
- BiologyOpen access
Triple-negative breast cancer (TNBC) remains an aggressive disease with limited treatment options. Oncolytic adenoviruses represent a promising platform, but their efficacy as single agents is often insufficient. This study examined whether an oncolytic adenovirus co-delivering d...
- BiologyOpen access
Asymmetric RBBP7 regulates the first cell fate decision of early mammalian embryos
Asymmetric transcription of noncoding RNA LincGET is currently recognized as the earliest event regulating the first cell fate decision in mammalian embryogenesis. However, whether key protein factors modulate this process remains elusive. Here, we identify RBBP7 as the earliest...